Medway Community Healthcare Medway NHS Trust Foundation Trust
Medway Clinical Commissioning Group Swale Clinical Commissioning Group

9.1.4. Platelet Disorders

Avatrombopag (Doptelet)

This High-Cost Drug has been approved for the following indications: - Treatment of primary chronic immune thrombocytopenia (ITP) refractory to other treatments (for example, corticosteroids, immunoglobulins) in adults.

For more information and NICE Guidance Click Here

Avatrombopag for treating primary chronic immune thrombocytopenia NICE TA853

Fostamatinib

This High-Cost Drug has been approved for the following indications: - Treatment of chronic immune thrombocytopenia (ITP) in adult patients who are refractory to other treatments.   

For more information and NICE Guidance Click Here Fostamatinib for treating refractory chronic immune thrombocytopenia NICE TA835

(Renal and Haematology use only)

Pack
100 capsule
  • First Line Choice
  • On Formulary
  • Specialist Initiation Only
  • Hospital Only
  • KMPT Initiation Only
  •